Form 144: Employee option sale of 7,900 STERIS shares valued $1.91M

Rhea-AI Filing Summary

STERIS plc reported a Form 144 notice for an insider sale of ordinary shares. The filing shows 7,900 shares offered through Charles Schwab & Co., with an aggregate market value of $1,909,646.00 and 98,490,606 shares outstanding for the company. The shares were acquired and are to be sold on 08/11/2025 via an employee stock option exercise using a broker payment for a cashless exercise.

The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer. Relationship to the issuer and the identity of the selling person are not specified in the visible fields.

Insights

Financial Analyst

TL;DR: Small insider sale from an employee option exercise; not clearly material to holders.

The Form 144 documents an intended sale of 7,900 ordinary shares of STERIS via Charles Schwab with an aggregate market value of $1,909,646.00, acquired and transacted on 08/11/2025 through a cashless exercise of employee stock options. The filing notes no sales in the prior three months and includes the standard attestation about undisclosed material information. Based on the filing content alone, this is a routine compliance notice documenting an insider sale tied to option exercise rather than a divestiture event; the filing does not provide detail on the seller's role or any broader corporate action.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; procedural Form 144 for an employee option exercise sale.

The notice lists the broker (Charles Schwab & Co.), the transaction type (cashless exercise of employee stock options), and key figures: 7,900 shares, aggregate value $1,909,646.00, and issuer outstanding shares 98,490,606. The filing contains the required attestation regarding material adverse information and reports "Nothing to Report" for prior three-month sales. The document does not disclose the filer’s relationship to the issuer or other contextual details that would affect governance interpretation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	7900	1909646.00	98490606	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/11/2025	Employee Stock Option Exercise	STERIS plc			7900	08/11/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for STERIS (STE) report?

The filing reports an intended sale of 7,900 ordinary shares of STERIS with an aggregate market value of $1,909,646.00 via Charles Schwab.

When were the shares acquired and when is the sale dated in the Form 144?

The shares were acquired on 08/11/2025 by an employee stock option exercise and the approximate date of sale is listed as 08/11/2025.

How were the shares paid for in the acquisition according to the filing?

The filing states the acquisition/payment method as a Broker Payment for Cashless Exercise following an employee stock option exercise.

Does the filing report any securities sold by the person in the prior three months?

No. The Form 144 section for securities sold during the past three months states "Nothing to Report".

Which broker is handling the proposed sale?

The broker named in the filing is Charles Schwab & Co., Inc. located at the address shown in the notice.

Does the Form 144 disclose the filer’s relationship to STERIS?

The visible filing fields do not specify the filer’s relationship to the issuer; that information is not provided in the displayed content.